|
|
Post by sbclives on Nov 8, 2021 12:14:51 GMT -5
Another scam robot. Ban them from this site.
|
|
|
|
Post by Willard Fillmore on Nov 9, 2021 0:14:46 GMT -5
Check Cassava Sciences(SAVA) a small biotech with a new drug, currently recruiting for Phase III trials. That will IMO be the the first to make a significant difference in the lives of Alzheimer patients. Phase II trials showed a reversal in lost cognitive abilities. From not knowing family members to again recognizing them. Also, being less argumentative. Not a cure, but an improvement in their lives. A year ago the stock price was around 10, then reaching 135 on 8/1. A prime candidate for the shorts to take advantage of by making a huge deal about a typo in a report, driving the price down to 42 in mid September. It closed at 90 today. Many feel they are a candidate for a buyout, in the not too distant future. Which should bring at least $150/share.
|
|
|
|
Post by Willard Fillmore on Nov 16, 2021 16:26:11 GMT -5
For those interested in gaining knowledge in Bio-tech stocks, without having to weed out the chaff and BS. There's a little known website, albeit the first to discuss the stocks of high tech companies. It has helped me tremendously in picking companies to invest in, with a good deal of success. The active participants are VERY knowledgeable, some trade as individuals in a small way and a huge way. Their research as a hole is as good as it gets and very transparent. They don't keep secrets, just the opposite, their purpose is to help others on the board. Doctors, lawyers, business owners, MULTI-millionaires alike, all good people. None trying to sell anything. Ask for comments about stocks(bio-techs for the most part) or guidance and they're willing to help. And it's free, although a little outdated from a technology aspect as websites go. After five years of experience with the site I feel confident suggesting it as a place that is worth your time. Google Silicon Investor, go to Biotech, find Immunomedics(always near the top of their list) and read. You won't be disappointed. I'm not getting a kickback, honest.  |
|
|
|
Post by Willard Fillmore on Nov 23, 2021 12:17:39 GMT -5
Check Aurinia Pharmaceuticals(AUPH). Who has a new drug approved for Lupus. They just made a new stock shelf offering that caused the share price to fall from 29 to 20. A buying opportunity, as there is a lot of talk that AUPH will be purchased sometime the first half of next year. An opportunity for a double.
|
|
|
|
Post by Willard Fillmore on Nov 23, 2021 18:41:52 GMT -5
The biotech sector is way down, looking for companies to put some money into for the inevitable rebound, here's another to look at.
CymaBay(CBAY), they have a drug in Phase III trials that has shown positive results in a liver cancer. The Hedge Fund AVORO, whose owner engineered the buyout of IMMU by Gilead, owns 15% of CBAY and just bought another 2.5 Million shares.
|
|
|
|
Post by Willard Fillmore on Mar 3, 2023 14:21:30 GMT -5
SRPT, my largest holding. has moved up almost $40 this week when the FDA made an announcement clearing the way for approval for its gene therapy for muscular dystrophy.
|
|
|
|
Post by Willard Fillmore on Mar 13, 2023 22:25:12 GMT -5
2 others doing well.
CBAY, my 2nd largest holding. Has quadrupled since the middle of last year.
SGEN, a smaller holding, has nearly doubled since the first of the year. Now that Pfizer has publicly announced they are going to buy them
|
|
